CRINETICS PHARMACEUTICALS IN
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CRINETICS PHARMACEUTICALS IN CALL, CUSIP 22663K907.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CRINETICS PHARMACEUTICALS IN CALL, CUSIP 22663K907.